|
| U.S. Brand
Names |
|
| Tussionex® |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Chlorpheniramine and Hydrocodone |

|
|
| Pharmacological Index |
|
|
Antihistamine/Antitussive |

|
|
| Use |
|
|
Symptomatic relief of cough and allergy |

|
|
| Restrictions |
|
|
C-III |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Adverse
Reactions |
|
|
<1% (Limited to important or life-threatening symptoms): Drowsiness,
sedation, lethargy, anxiety, facial pruritus, constipation, nausea, ureteral
spasm, respiratory depression, dryness of pharynx |

|
|
| Pharmacodynamics/Kinetics |
|
|
Duration: Hydrocodone: 4-6 hours |

|
|
| Usual Dosage |
|
|
Oral:
Adults: 5 mL every 12 hours; do not exceed 10 mL/24 hours
|

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
Prolonged use will cause significant xerostomia |

|
|
| Patient
Information |
|
|
Pregnancy precautions: Inform prescriber if you are or intend to be
pregnant. Do not breast-feed. |

|
|
| Nursing
Implications |
|
|
Shake well before administering |

|
|
| Dosage Forms |
|
|
Syrup, alcohol free: Hydrocodone polistirex 10 mg and chlorpheniramine
polistirex 8 mg per 5 mL (480 mL, 900
mL) |

|
|
Copyright © 2007 Drugs Area
|